AUG 24, 2021 6:00 AM PDT

Women Produce More COVID Antibodies Than Men

WRITTEN BY: Tara Fernandez

An exploration into the human immune response after a COVID-19 infection has revealed a surprising finding: women produce more antibodies to the coronavirus than men. The researchers, based at Tel Aviv University, found that age, the severity of COVID-19 symptoms, and the time since receiving a vaccine shot are also strong influencers of circulating antibody levels.

Antibodies are Y-shaped proteins that form a critical part of the immune system’s arsenal against pathogens. Once the body has been invaded by an infectious agent, short-lived cells known as plasmablasts produce some of the first antibodies to help resist infection. Subsequently, bone marrow plasma cells maintain long-term protection against germs, generating pathogen-specific antibodies for years after the initial infection. 

In the context of COVID-19, neutralizing antibodies latch onto the spike protein of SARS-CoV-2, stopping virus particles from entering host cells and causing disease.

​Researchers who were interested in what factors affect antibody production dynamics after COVID-19 examined over 25,000 blood samples taken from a cohort of study participants who had recovered from the disease. Women older than 51 were found to have higher SARS-CoV-2 antibody levels than men of matched ages. In men, rising antibody levels begin much earlier, starting around age 35. This phenomenon was hypothesized to be related to associated fluctuations in the sex hormones testosterone and estrogen. 

Moreover, individuals who had received both doses of a COVID-19 vaccine had three times stronger antibody responses than those who had naturally recovered from the disease. The authors suggest that the patterns observed may point towards differences in the overall health of the immune system (young adults have stronger immunities than older people). However, peaks in antibody levels in seniors often point to an exaggerated immune response as a result of very severe COVID-19 symptoms. 

The research was uploaded to the preprint server medRxiv
 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
JUL 27, 2021
Cell & Molecular Biology
Nanobodies May Prevent Complications From Infection in Transplant Recipents
JUL 27, 2021
Nanobodies May Prevent Complications From Infection in Transplant Recipents
In recent years, scientists java turned their attention to small antibodies that are produced by animals like sharks, ca ...
AUG 13, 2021
Cancer
Ultrasound Triggers Immunotherapy to Destroy Tumors
AUG 13, 2021
Ultrasound Triggers Immunotherapy to Destroy Tumors
An immunotherapy engineered to be triggered by ultrasound beams significantly slows the growth of cancerous tumors in mi ...
AUG 18, 2021
Cannabis Sciences
Cannabis Use Disorder Linked to COVID Hospitalization
AUG 18, 2021
Cannabis Use Disorder Linked to COVID Hospitalization
People with a genetic predisposition to cannabis use disorder (CUD) are more likely to require hospitalization after con ...
SEP 14, 2021
Immunology
The Spleen Creates Long-Lasting Protection Against the Flu Virus
SEP 14, 2021
The Spleen Creates Long-Lasting Protection Against the Flu Virus
You share an elevator with an individual who is coughing and sneezing, only to find yourself feeling unwell a few days l ...
SEP 13, 2021
Microbiology
Flu Season Looms Large as World May Have an 'Immunity Debt'
SEP 13, 2021
Flu Season Looms Large as World May Have an 'Immunity Debt'
Scientists are beginning to speculate about the possibility that the flu season this year will be particularly bad becau ...
SEP 21, 2021
Immunology
1 in 5 Hospitalized COVID Patients Develop Self-Destructive Antibodies
SEP 21, 2021
1 in 5 Hospitalized COVID Patients Develop Self-Destructive Antibodies
One in five hospitalized COVID-19 patients go on to develop autoantibodies—immune molecules that mistakenly target ...
Loading Comments...